Real-time enrollment status for this breast cancer invasive clinical trial
Current Status
Recruiting
Checked: July 17, 2026 at 10:48 PM UTC
| NCT Number | NCT04891068 |
| Recruiting Status | Recruiting |
| Condition | Breast Cancer Invasive |
| Phase | PHASE2 |
| Target Enrollment | 40 participants |
| Active Locations | 1 sites in the US |
| Sponsor | University of Illinois at Chicago |
| Last Updated on CT.gov | June 23, 2026 (3 weeks ago) |
As of July 17, 2026: Clinical trial NCT04891068 is currently recruiting participants. This phase2 study for breast cancer invasive is actively seeking new participants at 1 location across the United States. The study is sponsored by University of Illinois at Chicago. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT04891068 is actively recruiting participants as of July 17, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT04891068 was last updated 3 weeks ago (June 23, 2026). HelloStudys verifies this status automatically.